Close Menu
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    The Taiwan DailyThe Taiwan Daily
    • Home
    • Contact Us
    The Taiwan DailyThe Taiwan Daily
    Home » ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification
    ACCESS Newswire

    ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification

    October 3, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    BUFFALO, NY / ACCESSWIRE / October 3, 2023 / ZeptoMetrix® is pleased to announce it has been awarded an IVDR Quality Management System certificate from British Standards Institution BSI, NB 2797, one of the notified bodies under the new EU In Vitro Diagnostics Regulation (IVDR). This certificate applies to the majority of the current portfolio of CE marked ZeptoMetrix NATtrol™ quality control products that are the industry’s preferred brand for molecular diagnostic testing and are supplied ready-to-use as independent third-party quality control materials. With this significant certification step completed, ZeptoMetrix will focus on the implementation of updated product labelling over the next several months.

    “ZeptoMetrix is delighted with our smooth and efficient transition to IVDR,” commented Glenn Harrall, Global Vice President of Quality, ZeptoMetrix. “This transition reflects ZeptoMetrix continuous investments in quality programs, regulatory compliance and demonstrates our ongoing quality commitment to our partners and customers.”

    “Achieving this certification milestone is further demonstration of ZeptoMetrix’s commitment to supporting European clinical laboratories with reliable, innovative quality controls,” said Evangeline Gonzalez, President, ZeptoMetrix.

    For more information on ZeptoMetrix and NATtrol products, visit www.zeptometrix.com.

    About ZeptoMetrix®

    ZeptoMetrix, an Antylia Scientific company, is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services, have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    Related Files

    ZeptoMetrix Awarded IVDR Certification.pdf
    ZeptoMetrix IVD Product Portfolio.pdf

    SOURCE: ZeptoMetrix

    View source version on accesswire.com:
    https://www.accesswire.com/788946/zeptometrix-awarded-in-vitro-diagnostic-regulation-ivdr-certification

    Related Posts

    FQ-42 Vengeance Finds New Home at Creech Air Force Base

    September 21, 2026

    Bayer to Present How it Rebuilt Global Planning with OMP at Gartner Supply Chain Planning Summit 2026

    September 17, 2026

    GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops

    September 17, 2026

    GA-ASI Unveils Wildfire UAS for Military, Civil and Commercial Roles

    September 10, 2026

    OMP Asia Conferences to Showcase How Industry Leaders Kraft Heinz, Mars, Medac, And Nestlé Approach AI-Powered Supply Chain Planning At “Decision Velocity”

    September 8, 2026

    Slangit Technologies and GADEF International Launch Africa AI Literacy Initiative to Reach Five Million People

    August 25, 2026
    Latest News

    World Bank forecasts UAE economy to grow 5 percent in 2026

    September 26, 2026

    Developing Asia-Pacific economy set to grow 5% in 2026

    September 24, 2026

    Abdullah bin Zayed joins Trump talks with regional leaders

    September 23, 2026

    Egypt remittance inflows reach $29.7 billion by July 2026

    September 22, 2026

    Typhoon Dujuan hits eastern Japan with heavy rain

    September 21, 2026

    China holds 3% one-year LPR and 3.5% mortgage benchmark

    September 21, 2026

    Gene could raise lung cancer risk 60 times in study

    September 19, 2026

    DR Congo Ebola outbreak shows progress amid uneven trends

    September 17, 2026
    © 2026 The Taiwan Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.